This Solicitation opportunity from Department Of Defense was posted on May 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
BUTORPHANOL TARTRAT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Butorphanol Tartrate Injection, Veterinary, is a Schedule IV controlled substance marketed at a concentration of 10 mg/mL in 50 mL vials, specifically indicated for pain relief associated with colic in adult horses and yearlings. The product is supplied in single vial units of issue and must be stored at controlled room temperature between 20–25°C (68–77°F) in a secured location due to its DEA classification. It is subject to a non-extendable 24-month shelf life and must be marked in compliance with the latest Medical Marking Standard No. 1. The item is regulated by the FDA and requires referral through EBS to a product specialist prior to procurement, with mandatory inclusion of bidder and manufacturer details including NDC numbers and part identifiers from authorized suppliers such as Merck Sharp & Dohme LLC, Zoetis Inc., and Covetrus North America, LLC. Packaging and handling must adhere to MIL-STD-2073-1E specifications and DLA packaging requirements, with all technical and quality standards referenced from the DLA Master List of Technical and Quality Requirements. This procurement under contract SPE2DP-26-T-3283 involves a single vial quantity with no tolerance for variance in delivery quantity, delivery to be completed within 20 days FOB destination, with inspection and acceptance occurring at the delivery point. The NSN is 6509-01-531-0967, and the solicitation was posted on May 6, 2026, with responses due by May 12, 2026, under a federal acquisition framework managed by the Department of Defense’s Medical Supply Chain.
General Info
Agency
NAICS
Place of Performance
UNIT 5268, APO, AP, 96368-5268, USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
BUTORPHANOL TARTRATE INJECTION, VETERINARY
.
10 MG/ML, 50 ML VIAL; FOR PAIN RELIEF ASSOCIATED WITH
COLIC IN ADULT HORSES AND YEARLINGS;
DEA SCHEDULED DRUG CLASS IV
.
UNIT OF ISSUE: VIAL (VI) OF 50ML.
.
STORE AT CONTROLLED ROOM TEMPERATURE 20-25C (68-77F); SECURED (C-IV)
.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/ .
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . .. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
MERCK SHARP & DOHME LLC 6B2S4 P/N 017070 MWI VETERINARY SUPPLY, INC. 1VLG2 P/N NDC67185-0722-66 ZOETIS INC. 0M1P3 P/N 10009984 ZOETIS INC. 0M1P3 P/N NDC54771-2033-20 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 029088 PATTERSON VETERINARY SUPPLY, INC. 3G5T7 P/N 07-803-7090
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3283
SECTION B
PR: 7016655669 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016655669 0001 VI 1.000
NSN/MATERIAL:6509015310967
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6509-01-531-0967 Quantity: 1 VI Purchase Request: 7016655669QTY: 1 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS